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Slllmmsry 
Infection with a sexually transmitted disease (STD) increases the risk for human immunodefidency 
virus (HIV) infection. Polymorphonuclear leukocytes (PMNs) are recruited into the genital tract 
by STD pathogens,  such as Chlamydia  trachomatis.  Semen of HIV-infected men contains  HIV 
associated with mononuclear cells. This study investigated the interaction among PMNs from 
HIV-uninfected persons,  C.  trachomatis,  and HIV-infected cells and examined  the mechanisms 
for enhanced HIV replication. We demonstrated that PMNs from HIV-seronegative donors in- 
duced HIV replication in mononuclear cells from 17 HIV-infected patients in medium without 
exogenous II-2. HIV in the cell-free supernatants from cocultures of PMNs and patients' periph- 
eral blood mononuclear cells (PBMCs) was replication competent, as indicated by their capacity 
to propagate HIV in a second round of culture using PBMCs from HIV-seronegative individuals 
and by the fact that proviral DNA was found in these cells. PMNs from HIV-seronegative donors 
increased HIV replication over 100-fold in chronically HIV-infected cell lines of the monocytic, 
T,  and B cell lineages.  Moreover,  PMNs increased U1 cells' production  of p24 antigen by as 
much as ninefold when compared with U1 cells cocultured with PBMCs. The addition of C. 
trachomatis  to PMN and U1 coculture increased HIV replication by an additional  ninefold at 
24 h, whereas C.  trachomatis  alone had no effect on p24 antigen production by U1 cells. Thus, 
C. trachomatis  serves not only to recruit PMNs, but also to interact with PMNs to increase HIV 
replication.  HIV replication is triggered by contact of HIV-infected cells with PMNs, by the 
generation of reactive oxygen intermediates (KOIs), and by soluble factors such as TNF-c~ and 
II,-6. This is based on the findings that production of p24 antigen,  IL-6, and TNF-c~ induced 
by PMNs is abrogated by disrupting or partitioning PMNs from HIV-infected cells; is inhibited 
by superoxide dismutase and catalase,  enzymes that destroy KOIs; is enhanced by differentiated 
HL60 cells capable of producing ROIs; and is induced by PMNs tested negative for CMV. Fur- 
thermore, the production of KOIs is independent of HIV infection of mononuclear cells, since 
PMNs cocultured with HIV-uninfected parental  monocytic and T  cell lines generated  KOIs. 
Therefore,  the increased risk for acquiring HIV infection associated with chlamydia cervicitis 
may be related to the local recruitment of PMNs by C. trachomatis and the induction of infectious 
virus from mononuclear cells present in semen. These observations provide a rationale for strate- 
gies to reduce HIV transmission  by control of STD. 
T 
he World  Health  Organization  and  Centers  for Dis- 
ease Control  and Prevention  (CDC) t  estimate that  as 
of 1993 over 12 million persons were infected with HIV world- 
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wide, with I million in the USA (1). Within the USA, the 
risk of male-to-female transmission is estimated at less than 
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infected partner (2-4).  Although the risk for each episode 
of  penile-vaginal intercourse is not known for developing coun- 
tries,  the rapidly increasing rates of HIV infection in these 
countries with similar rates in men and women suggest that 
the risk during heterosexual activity is significantly higher 
(1). Since anal intercourse is rarely reported in these regions, 
cofactors for enhanced transmission during vaginal intercourse 
have been sought (5,  6). 
Epidemiologic studies have implicated sexually transmitted 
disease (STD) as a cofactor for HIV seroconversion (reviewed 
in references 5-7). These reports raised the possibility that 
preexisting STD may alter the host's susceptibility to and/or 
enhance the efficiency of HIV transmission. Although gen- 
ital ulcers  caused by some STDs may provide a portal for 
HIV entry, Chlamydia trachomatis infection and other nonulcer- 
producing STDs are also associated with an increased  risk 
for HIV seroconversion  (7-10).  An intense PMN infiltrate 
in the genital tract in which neutrophils predominate is a 
distinguishing feature of symptomatic and asymptomatic 
chlamydia cervicitis  (11, 12). 
Transmission of HIV from men to women occurs because 
semen contains infectious HIV (13-15). Semen of HIV-infected 
men contains mononuclear leukocytes,  and the presence  of 
HIV seems not to be influenced by the stage of HIV disease 
(13-15).  HIV in semen is predominantly cell associated (13, 
16), most likely with leukocytes, but may be carried by sperm 
(17, 18). Cell-free HIV is seldom found without cell-associated 
virus (13, 16). Although infection of a woman by an HIV- 
infected man is probably due to the presence of  HIV in semen, 
the mechanism for the increased  risk for HIV infection in 
some women remains undefined. 
Because the PMN infiltrate is a feature of many STDs, in- 
cluding chlamydia disease, and because the ability of PMNs 
to trigger HIV production has not been demonstrated, we 
examined the effect of PMNs and chlamydia on induction 
of HIV replication from HIV-infected patients' PBMCs and 
chronically HIV-infected cell lines. In vitro induction of HIV 
replication from HIVoinfected  mononuclear cells has been 
reported to require cocuhure with activated mononuclear cells 
from HIV-seronegative donors and exogenous ILo2. This study 
reports that PMNs from HIV-seronegative persons trigger 
HIV replication from HIV-infected persons' mononuclear cells 
without exogenous IL-2 and that chlamydiae additionally en- 
hance this process. The mechanisms for the interaction among 
PMNs, chlamydiae, and HIV-infected cells are presented and 
may point to an additional strategy for decreasing HIV trans- 
mission. 
Materials and Methods 
Materials and Reagents.  The materials and reagents used and 
the respective manufacturers were as follows: RPMI 1640, HBSS, 
penicillin/streptomycin, L-glutamine, and  FBS  (GIBCO  BRL, 
Gaithersburg, MD); Ib2 (Boehringer  Mannheim, Indianapolis,  IN); 
PHA, catalase (CAT), superoxide  dismutase (SOD), dextran, Ficoll, 
and PMA (Sigma Chemical Co., St. Louis, MO); 76% Hypaque 
(Winthrop Pharmaceuticals, NY); 25-cm  2 tissue culture flasks and 
24-well culture plates (Coming Glass Works, Coming, NY); HIV-1 
antigen kits, p24 antigen standard, 0.9%  NaC1 solution, sterile 
water, Quantum II Dual Wavelength Analyzer, and Qwikwash 
Bead Washing System (Abbott Laboratories, North Chicago, IL); 
Taq polymerase and gene amplification kit (Perkin-Elmer-Cetus, 
Norwalk, CT); SK38/SK39 gag oligonucleotide primers (gift of 
Dr. C. Y. Ou, CDC, Atlanta, GA, and Research Genetics, Hunts- 
ville, AL); CMV oligonucleotide primers and probe (Research 
Genetics); hybridization protection assay with acridinium ester 
(AE)-labeled oligonucleotide gag  gene probes and Leader-5 lu- 
minometer (AccuSearch kit; GenProbe, San Diego, CA); 0.2-tim 
membrane inserts for tissue  culture (Millipore  Corp., Bedford,  MA); 
Centicon microconcentrators (Amicon Division, Danvers, MA); 
CMV  IgM-  and IgG-specific immunoassays (Diamedix Corp., 
Miami, FL); and cytokine  enzyme immunoassay  (EIA, Predicta kits; 
Genzyme Corp., Cambridge, MA). 
Cell Isolation and Culture.  Heparinized peripheral blood and ci- 
trate leukocyte-rich  burly coat of  normal healthy HIV-seronegative, 
low risk donors were obtained, respectively, from volunteers and 
from the American Red Cross (Portland, OR). PBMCs separated 
by Ficoll Hypaque gradient centrifugation (19, 20) were washed 
twice with 0.9% NaC1 and suspended in complete media (RPMI 
1640 with 10% FBS, 2 mM t-glutamine, 100 U/ml penicillin, 100 
#g/ml streptomycin) at 3-5  x  106 cells per ml and stimulated 
with PHA (2 ttg/ml) for 24-48 h at 37~  and 5% CO2. PMNs 
(>99.9% granulocytes, of which t>95% were neutrophils) were 
separated from red blood cells by dextran sedimentation (3% dex- 
tran in 0.9% NaC1 solution, I g, 30 min) (21). Residual red blood 
cells were removed  by hypotonic  lysis. The purified  neutrophils were 
>95%  viable as judged by trypan blue exclusion. 
HIV-infectedPatients'PBMCs.  17 HIV-seropositive  patients from 
The New York Hospital were recruited, each donating 20 ml of 
whole blood.  11  of 17  (65%)  had AIDS with CD4 + T  cells 
<200/#1 and AIDS defining illness; 6 (35%) were asymptomatic 
with CD4 § T cell counts >~500/#1. The patients' PBMCs were 
isolated by Ficoll Hypaque density centrifugation. The viral cul- 
ture was performed by a quantitative coculture method as reported 
by Ho et al. (22). 10-fold dilutions of HIV-seropositive patients' 
PBMCs (2  x  106 to 2 ￿  103 cells per well) were cocultured with 
heterologous, washed, PHA-stimulated PBMCs (2  x  106 cells per 
well) or PMNs (2  x  106 cells per well) freshly isolated from HIV- 
seronegative  donors in a total volume  of 1.5 ml of  complete medium 
either with or without 10% (vol/vol) IL-2. During the 21-d cul- 
ture, seven harvests (50% medium change) were performed every 
2-4  d.  Fresh PMNs (2  x  106 cells per well) were added once 
weekly, but there were no additional PBMCs. Quantitative cocul- 
tures of six asymptomatic  HIV-infected  patients, using PBMCs from 
HIV-seronegative donors, ranged from 0.5 to 5,000 tissue culture 
infective doses (TCID) per 106 PBMCs (n  =  6). 
Chlamydia trachomatis.  The L-2 serovar of C. trachomatis (from 
Dr.  C.  P,  othermel  or the  American Type Culture  Collection, 
[ATCC] VR-902B, Rockville, MD) was propagated in L cells, and 
elementary bodies (EBs) were purified by renografin gradient cen- 
trifugation and stored at  -70~  (23, 24). The preparations con- 
tained 1011 to 1012 viable EBs, as determined by titration in L cells 
(23). Five IDs0s were added to PMNs or PBMCs cocultured with 
HIV-infected patients' PBMCs or cell lines. 
HIV-infected Cell Lines.  The chronically HIV-infected mono- 
cytic cell line U1 and T cell lines ACH-2 and 8E5 cells were ob- 
tained from Dr. Tom Folks (CDC) (25, 26). The chronically HIV- 
infected B cell line B-HIV1 was derived  as previously  described (27). 
U1, T, and B cells (from 2  x  102 to 2  x  10  s cell per ml) were 
cocultivated  in complete medium (no IL-2)  with or without donor 
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FBS. For evaluations of reactive oxygen intermediates (ROIs) stimu- 
lated with PMA (50 ng/ml) or PMNs (2  x  106 cells per ml), U1 
cells were cultured with medium or medium containing CAT (58 
#g/ml) and SOD (300 U/ml), or heat-inactivated (100~  1 h) CAT 
(58 #g/ml) and SOD (300 U/ml). The percent inhibition of the 
stimulated U1 cells' production of HIV p24 antigen was defined 
as follows:  100  x  [1  -  (experimental condition/stimulated U1 
ceils)]. 
EIA for the Detection of HIV-1 p24 Antigen in Viral Culture Super- 
natants.  The amount of HIV in culture supernatants was quanti- 
tated by commercial p24 antigen capture EIA (Abbott Laborato- 
ries). Briefly, culture supernatants diluted 2-200 times in culture 
medium were tested as described by manufacturer's protocol. Ac- 
tual amounts of p24 were determined by using standards provided 
by the manufacturer (Abbott Laboratories). OD values of controls 
and culture supernatant were determined at 492 nm using an EIA 
reader (Abbott Laboratories), and OD values of the supernatant 
from HIV-seronegative donor cells were always below the cutoff 
for negative controls. 
Propagation of HIV by Secondary Culture.  Cell-free culture su- 
pernatants (200/~1, stored at  -70~  were incubated with PHA- 
stimulated PBMCs (4  x  10  6)  from HIV-seronegative donors in 
growth medium for 24 h  at 37~  5%  CO2. The residual  free 
virus was removed by washing and culturing for 21 d as described 
for primary HIV coculture. On day 21, cells were pelleted, washed, 
and dissolved in DNA lysis buffer (10 mM Tris HC1, pH 8.3, 50 
mM  KCI,  7.5  mM  MgClz,  0.45%  NP-40,  0.45%  polysorbate 
[Tween] 20,  0.1  mg/ml gelatin) (28). 
Detection of HIV gag Gene from Secondary Culture Cells by PCR 
and Oligonucleotide Probes.  Cell  lysates  containing  DNA  were 
digested of protein with 100/~g/ml proteinase K at 65~  for 1 h 
and with proteinase K inactivated by heating at 95~  for 10 min. 
DNA obtained from the 8E5 T cell line (gift of C. Y. Ou, CDC) 
has a single copy of integrated HIV-1 proviral DNA per cell. This 
was diluted so that each PCR contained 0, 1, 2, 4, 8, 16, 31, 62, 
125,250, 500, and 1,000 copies of HIV-1 proviral DNA extracted 
from the 8E5 T cell line and a constant amount of HIV-seronegative 
DNA background derived from 250,000 PBMCs (29, 30). Approx- 
imately 1.5/xg of DNA was used, representing 250,000 cells from 
each sample, gag gene PCR amplification was performed using oli- 
gonucleotide primers (SK38/SK39), reaction mix, and thermal cy- 
cler conditions (28, 30). In brief, amplification was performed for 
35 cycles in a DNA thermal cycler (Perkin  Elmer Cetus) under 
the following conditions: room temperature to 95~  1 min 30 s; 
95~  I min; 95~176  I min 30 s; 55~  30 s; 55~176  30 s; 
60~  2 min 30 s. 
Detection of  Amplified HIV1 DNA Using AE-labeled Probes.  The 
hybridization protection assay using AE-labeled  oligonucleotide 
probes and reagents are commercially available (AccuSearch kit, Gen- 
Probe). Two overlapping AE-labeled  oligonucleotide probes, gag 
I andgag 2, were used to reduce the potential loss in signal resulting 
from mismatches between the probe and SK38/SK39-amplified HIV-1 
DNA (30). Amplified DNA (25 #1) and an equal volume of a buffer 
containing 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 0.45% NP-40, 
0.45% polysorbate (Tween) 20, and 0.1 mg/ml gelatin were added 
to a polypropylene test tube (Stockwell Scientific, Alnut, CA). The 
mixture was heated at 95~  for 5 min in a water bath to allow 
dissociation  of double-strand DNA and was immediately placed 
in ice water to maintain the separated DNA as single-strand  con- 
formation. Probe mixture (50/~1) containing 0.02 pmol of each 
probe, 0.1 M lithium succinate buffer, pH 4.7, 2% (wt/vol) lithium 
lauryl sulfate, 1.2 M LiC12, 20 mM EDTA, and 20 mM EGTA was 
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added.  Hybridization of the probe and amplified  DNA was per- 
formed at 60~  for 30 min, and the reaction was quickly termi- 
nated by cooling in ice water for 2 min. After the addition of hy- 
drolysis buffer (300/~l)  containing 0.6 M sodium borate, pH 8.5, 
1% Triton X-100 was added, and the mixture was vortexed briefly 
and placed at 60~  for another 10 min to hydrolyze AE groups 
on unhybridized probes. Samples cooled on ice (2 rain) and warmed 
to room temperature (2  min) were analyzed by a luminometer 
(Leader-50,  GenProbe) equipped with automatic injection of de- 
tection reagent I (containing 0.1% hydrogen peroxide and 1 mM 
nitric  acid)  and  detection reagent  II  (containing  1  N  sodium 
hydroxide and a  surfactant component).  Quantities  of emitted 
photons were measured by the luminometer, and the results were 
expressed as relative light units.  Using dilutions of 8E5 T  cells, 
the AE-labeled probes were able to detect 1-1,000 copies of HIV 
gag gene per PCR (30). 
Sulx,'roxide Assay.  Neutrophils or PBMCs obtained from healthy, 
HIV-seronegative donors or U1, U937, or HL60 promyelocytic cells 
in 0.1 ml of complete medium or HBSS (pH 7.2) were added to 
triplicate wells of a 96-well flat bottom microtiter plate. Assays for 
superoxide  generation were performed (20,  31). Cells  incubated 
(37~  5 rain) with cytochrome C (0.025 ml, 0.001 tool/liter) were 
either cocultured with U1 cells (2  x  105 to 2  x  103) or treated 
with medium or with medium containing PMA (5/zM), CAT (58 
#g/ml, 7 U per ~g of protein), and/or SOD (300 U/ml); superoxide 
was monitored at the designated times.  For all conditions, simul- 
taneous controls containing 0.025 ml of 0.1 mg/ml SOD were set 
up in parallel.  Absorbance of the cell suspensions  was measured 
at 540 and 550 nm using an IBM-compatible 386 computer-assisted 
automated microtiter plate reader (model EL340; Bio-Tek Instru- 
ments Inc., Winooski, VT). The OD at 550 and 540 nm was com- 
pared in duplicate samples with and without SOD, and superoxide 
production was calculated  as the SOD-inhibitable reduction of 
cytochrome C,  using  the extinction coefficient  of 2.11/mmol/ 
liter/cm (20). 
Culture and Differentiation of ilL60 Promyelocytic Cells.  HL60 
cells (CCL240; ATCC) were cultured in complete medium. Cells 
were differentiated by 1.3% DMSO  over 6-9 d. Differentiation 
by DMSO is associated with morphologic maturation from promye- 
locytes to bands and neutrophils with the capacity to phagocytose, 
secrete primary granular enzymes, and rapidly generate ROIs in 
response  to PMA and zymosan (31). 
Detection of CMV.  Healthy laboratorians  were screened by EIA 
(Diamedix Corp.) for the presence of CMV-specific IgM and IgG 
antibodies  at the clinical laboratory of The New York Hospital. 
PBMCs and PMNs from CMV serology-tested donors were ob- 
tained as previously described and used for cocultures or for detec- 
tion ofCMV DNA. PBMCs, PMNs, or HL60 cells were dissolved 
in DNA lysis buffer at 4  x  107 cells per ml and were treated for 
16 h with proteinase K as previously described. Human embryonic 
fibroblasts (HEFs; Baxter Bartels, Issaquah, WA) were infected with 
CMV (1993 proficiency  testing isolate [sample 603],  Laboratory 
for Virology, Wadsworth Center for Laboratory Research, New 
York State Department of Health, Albany, NY) and cultured for 
6 d, at which time maximal numbers of cells showed cytopathic 
effects characteristic of intracellular  CMV propagation. Superna- 
tant and cells from five culture tubes concentrated by centrifuga- 
tion at 200,000 g for 2 h were dissolved in DNA lysis buffer and 
treated with proteinase K as previously described.  Purified DNA 
was obtained by extraction with phenol-chloroform and ethanol 
precipitation and suspended in 10 mM Tris, 1 mM EDTA, pH 7.4 
buffer.  Approximately 1.5-5.5/zg of DNA from CMV-infected 
HEFs or healthy donors was used to perform PCR to detect the major immediate early antigen (lEA) using 50 pmol of  each primer 
complementary  to the IEA (nucleotide  2038-2300; upstream primer: 
5'-GGT GCT CAC GCA CAT TGA TC-Y; downstream primer: 
5'-AGA CCT TCA TGC AGA TCT CC-Y)  (32-34).  The mix- 
ture was subjected to 50 cycles of amplification. Each cycle was 
performed at 94~  for 1 min,  55~  for 2 min, and 72~  for 3 
min. 20/~I of each amplified sample was electrophoreticaUy sepa- 
rated on 1.5% agarose gel, stained with ethidium bromide, pho- 
tographed, and transferred onto nylon by diffusion. The membrane 
was probed with 5' or 3' 32p end-labeled oligonucleotide com- 
plementary to the internal sequence of the IEA (probe: 5'-CTA 
GTG TGA TGC TGG CCA AGC GGC CTC TGA-3'). PCR per- 
formed on DNA from CMV-infected HEFs (1.5-5.5/~g)  diluted 
with 1.5 #g of DNA from PMNs of a CMV-seronegative donor 
was positive for CMV and was similar to samples not mixed with 
DNA from CMV-seronegative  PMNs. CMV-positive samples con- 
tained a 262-bp fragment and were positive by Southern analysis. 
Cytokine Assays.  Commercial EIAs were used for detection of 
TNF-cr and II.-6 (Genzyme Corp.). Interference was not detected 
by EIA in RPMI 1640 with 10% FBS. The following cytokines 
did not cross-react with the TNF-c~ assay kit: murine TNF-c~, Ib 
3, IL-l-ot and IL-I-~, IL-4, platelet-derived growth factor (PDGF), 
Ib2, Ib6, GM-CSF, epidermal growth factor (EGF), basic fibro- 
blast growth factor (FGF), IFN-% and TNF-~. The following 
cytokines did not cross-react with the Ib-6 assay kit: TNF-c~, EGF, 
basic FGF, GM-CSF, IFN-% Iblc~ and Ibl-~, Ib2, Ib4 G-CSF, 
PDGF, and insulin-like growth factor 1. The assay was performed 
as described by the manufacturer, absorbance was read at 450 nm 
(Bio-Tek Instruments  Inc.), and a standard curve was constructed 
to quantitate 1I.-6 concentrations in controls and undiluted or seri- 
ally diluted samples of culture  supernatants. 
Statistical Analysis.  Data were analyzed using analysis of vari- 
ance (ANOVA) and Kruskal-Wallis statistics, the respective para- 
metric and nonparametric tests for repeat measures of  multiple treat- 
ments (SAS software, version 6.04; SAS Institute Inc., Cary, NC). 
In addition, comparisons between two groups with single mea- 
sure were analyzed by Student's t test of paired samples and Wil- 
coxon signed rank,  the respective parametric and nonparametric 
tests. The alpha level was set at 0.05. Values are expressed as mean 
_+  SEM, unless otherwise indicated, n defines the number of in- 
dividual experiments, each using a different single donor. 
Results 
PMNs from HIV-seronegative Donors Induce HIV Replication 
by Mononuclear Cells from HIV-seropositive Patients.  We in- 
vestigated the interaction among PMNs  and HIV-infected 
mononuclear ceils because PMNs are the predominant cells 
recruited during acute STD.  Coculture with  mitogen-sti- 
mulated PBMCs from HIV-seronegative donors and IL-2 is 
the standard method to induce HIV replication from HIV- 
seropositive patients' mononuclear cells (35). Using this cocul- 
ture of "mixed lymphocytes" the reported rates of positive 
viral cultures varied from 70 to 100% (35). As expected, we 
did not detect HIV p24 antigen when mononuclear cells from 
HIV-seropositive patients were cultured alone in medium or 
in medium containing 10% IL-2 (n  =  3 and 13; Fig.  1). In 
contrast, PMNs from HIV-seronegative donors in the absence 
of exogenous Ib2 triggered HIV p24 production by mono- 
nuclear cells obtained from 17 patients (Fig.  1). The PMN- 
induced production of HIV p24  antigen by HIV-infected 
H1  H2  H3  H4  H5  H6  H7 
Harvest  Interval 
HIV-infected  monocuclear  cells  co-cultured  with: 
z~  PMN  0  PBMC  ￿9  PMN  +  11,2  ￿9  PBMC  +  112. 
/2  Medium  ￿9  IL~2 
100 
Figure  1.  PMNs  from HIV-seronegative  donors induced HIV replica- 
tion by mononuclear  cells from HIV-infected  patients. Illustrated are the 
results (mean _+ SEM) of 17 separate  HIV-infected  patients' mononuclear 
cells (2  x  106) cocultured  with heterologous  PMNs or PBMCs (each 2 
x  10~)  from  low risk, HIV-seronegative  volunteers  in medium containing 
or lacking 10% 11:2. A significant increase over time in the amount of 
HIV p24 antigen was observed  for PMNs and PBMCs cocultured  with 
patients' mononuclear  cells  in medium  containing  or lacking  I1:2 (F <0.05, 
Kruskal-Wallis statistics). In the absence of II:2, the production of p24 
antigen in cocultures  with PMNs was significantly  higher  than the produc- 
tion with PBMCs (p < 0.05, Kruskal-Wallis statistics). PMNs (2 x  106) 
and PHA-stimulated  PBMCs (2  x  106)  obtained  from HIV-seronegative, 
low risk volunteers  were cultured with PBMCs of HIV-infected  patients 
(2  x  106 PBMC) for 21 d with one-half  volume medium change every 
2-4 d for harvest (H) intervals 1-7. In data not shown, lower  dilutions 
of HIV-infected  patients' PBMCs (2  x  10  s to 2 x  103)  cocultured  with 
I1:2 and PMNs or PBMCs from  HIV-seronegative  donors produced  similar 
amounts of HIV p24 antigen (n  =  6). 
mononuclear cells increased significantly over time (p <0.05, 
Kruskal-Wallis  statistics,  n  =  17). 
Continuous p24 antigen production by HIV-infected pa- 
tients' mononuclear cells required weekly addition of PMNs. 
Without further addition of PMNs, a burst of p24 antigen 
reached by harvest 3 rapidly fell to undetectable levels (n  = 
3). The requirement for the weekly addition of fresh PMNs 
is due to loss of PMNs from cell death. When PMNs were 
cultured alone, 96  +  1% (SD) of the PMNs were viable at 
the initiation of culture. By day 3, only 0.3% of the PMNs 
were viable in medium containing or lacking II.-2, and >80% 
of the cells' nuclei had disintegrated when compared with 
the first day of culture. By day 7 of culture, almost no nuclei 
were observed. 
Even though HIV-seronegative donors' PMNs or PBMCs 
induced similar kinetics of p24 antigen production, PMNs 
in medium lacking Ib2 induced significantly greater amounts 
of p24 antigen than PBMCs from the same donors (Fig.  1, 
p <0.05,  Kruskal-Wallis  statistics).  In the presence of 10% 
IL-2, similar levels of p24 antigen were induced by PMNs 
and PBMCs. The lack of constitutive production of p24 an- 
tigen by HIV-infected patients' mononuclear cells, the require- 
ment for the weekly addition of PMNs,  and the induction 
of p24 production by PMNs in medium without IL-2 pro- 
vide evidence that PMNs triggered HIV replication from HIV- 
infected mononuclear cells. 
Cell-free Supernatants from Cocultures of PMNs or PBMCs 
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competent HIV.  Cell-free viral supernatants were tested for 
replication-competent HIV because myeloperoxidase of neu- 
trophils had been reported to deactivate HIV (36).  Fig. 2 il- 
lustrates the propagation of HIV in a second round of viral 
cultures using cell-free supernatants of each coculture condi- 
tion shown in Fig. 1. A time-dependent increase in new p24 
antigen was detected in secondary cultures using the ceU-free 
supernatants from cocultures of patients' mononuclear cells 
with either PMNs or PBMCs from HIV-seronegative  donors 
(n =  4 separate patients).  The kinetics of  p24 antigen produc- 
tion in the second round of cocultures were comparable to 
those in the primary culture even though only 200 #1 of the 
1,500-#1 total volume of the cell-free supernatant from the 
primary culture was used. 
To confirm further that the HIV in the primary culture 
supernatant was infectious, the presence of HIV proviral DNA 
resulting from the reverse transcription of viral RNA in the 
cells of the secondary cultures was evaluated.  HIV provirus 
was detected by gag gene PCR and probes in the secondary 
cultured cells' DNA (Table 1). The finding of increasing p24 
production and HIV provirus in the secondary cultures indi- 
cates that the supernatants from primary cultures of HIV-in- 
fected patients with either PMNs or PBMCs from HIV-sero- 
negative donors contained replication-competent HIV. 
Effect of  PMNs and C. trachomatis on HIV Production by UI 
Cells.  Since PMNs from HIV-seronegative donors can in- 
dependently trigger HIV replication by mononuclear cells 
from HIV-infected patients, we questioned whether C. tracho- 
matis could additionally increase HIV replication. Chroni- 
100  ￿9 
10. 
i, 
i  0.1 
0,01  H  ~  I 
H1  H2  3  H~.  H5 
Harvest  Interval 
Cell  free  supernatant  from  co-cultures  of 
HIV-infeeted  mononuclear  cells  with: 
z~  PMN  O  PBMC 
￿9  plan  +  IL2  ￿9  PBMC +  IL2 
Figure 2.  Propagation  of HIV from coculture supernatants  of PMNs 
or PBMCs from HIV-seronegative  donors with HIV-infected  patients' 
mononuclear  cells. Cell-free  supernatants  (200/*1) from  cocultures  of HIV- 
infected  patients' mononuclear  cells with HIV-seronegative  donors'  PMNs 
or PBMCs  from  Fig. 1 were  used  for a second  round  of  viral culture  using 
PHA-stimulated HIV-seronegative  donor PBMCs. A time-dependent  in- 
crease in p24 production was seen in the second round of viral cultures 
(p  = 0.05, ANOVA and Kruskal-Wallis  statistics). The results are the 
mean + SE of four different  patients' primary  cultures, each with two 
donors, representing 32 separate secondary  cultures. One-half  volume 
medium was changed every 2-4 d for harvest (H) intervals 1-5. 
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Table 1.  Cell-Free  Supernatants from  Cocultures of 
HIV-Infected Patients' Mononuclear Cells with PMNs or 
PBMCs from HIV-Seronegative Donors Contain 
Replication-Competent Virus 
Propagation of HIV from 
cocultures of HIV-infected 
patients' mononuclear 
cells with 
Copies of HIV per 
106 cells from 
secondary culture 
PMNs  70  +_  18 
PBMCs  25  _+  10 
PMNs  +  IL-2  20  _+  10 
PBMCs  +  IL-2  100  _+  35 
Second-round  viral  cultures  were performed  with PHA-stimulated  HIV- 
seronegative  donor PBMCs and cell-flee  primary  culture supernatants  from 
HIV-seropositive patients' cells cocultured  with PMNs or PBMCs from 
HIV-seronegative donors and without or with IL-2. After 21 d of cul- 
ture, DNA was extracted from donor PBMCs of secondary  culture and 
amplified  by PCR for HIV gag gene. The copies of HIV provirus were 
determined by comparison  with dilutions  of 8E5 T cells. The results are 
the mean _+ SE of four separate patients' primary  cultures, representing 
32 secondary  cultures. 
cally HIV-infected cell lines were used because they permit 
standardization of viral load, since the cell lines used contain 
either a single or a double copy of the HIV genome. 
The interactions between chronically HIV-infected mono- 
cytic cell line, PMNs, and C. trachomatis are illustrated in Fig. 
3. HIV p24 antigen production induced by PMNs increased 
in a time-dependent manner (n =  19, p <0.05, ANOVA and 
Kruskal-Wallis  statistics).  PMNs significantly enhanced the 
overall production of p24 antigen by U1 cells by 100-fold 
or more. The enhancement of HIV replication by PMNs was 
at  least  10-fold  greater  than  that  by PBMCs  (p  <0.05, 
ANOVA and Kruskal-Wallis statistics).  The higher produc- 
tion of HIV p24 antigen by U1 cells cocultured with PMNs, 
compared with PBMCs in medium without IL-2, was similar 
to the induction of HIV observed for HIV-infected patients' 
mononuclear cells in  medium lacking IL-2. Furthermore, 
(2. trachomatis in the presence of PMNs additionally increased 
up to 10-fold HIV replication in U1 cells and was significantly 
greater than that in U1 plus PMNs or U1 plus PBMCs (p 
<0.05, ANOVA and Kruskal-Wallis  statistics).  In contrast, 
C. trachomatis in the absence of PMNs did not enhance p24 
antigen production by U1 cells (n  --  3;  data not shown). 
The enhancement of HIV replication by PMNs was also 
observed with lower (2  x  103) or higher (2  x  10  s) U1 cell 
concentrations. However, the differences were less at higher 
U1 cell concentrations because of constitutive production of 
p24 antigen (n  =  3; data not shown). Using HIV-infected 
patients' PBMCs, C. trachomatis in the presence of PMNs in- 
duced amounts of p24 antigen that were greater than those 
in cocultures containing PMNs and HIV-infected mononuclear 
cells from the same patients (n =  3; data not shown). There- 
fore, chlamydia induction of HIV required PMNs, because 
p24 antigen production by U1 cells or HIV-infected patients' 10  4. 
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Figure 3.  PMNs  and C. trachoraatis  enhanced HIV replication in HIV- 
infected U1 monocytic cells. U1 cells (2  x  104) in complete medium 
lacking Ib-2 were cocuhured with PMNs (2 x  106)  or PBMCs (2  x  106) 
from HIV-seronegative  donors and with or without five  ID~ of C. tracho- 
marls (Ct.). Significantly  higher p24 antigen was produced by U1 cells 
cultured with PMNs than U1 cells alone or U1 cells plus PBMCs (n  = 
17, p <0.05,  ANOVA and Kruskal-Wallis statistics). The addition of 
C. trachomatis to U1 cells in the presence  of PMNs further increased p24 
antigen production above  that of U1 cells with PMNs; C. trachomatis  had 
no effect  on p24 antigen production by U1 cells or U1 cells plus PBMCs 
(n  =  5, p <0.05, ANOVA and Kruskal-Wallis statistics). Statistically 
significant increase over time in the amount of p24 antigen was observed 
for U1 cells, U1 cells plus PMNs, and U1 cells plus PMNs and C. tracho- 
raatis (n =  19, p <0.05, ANOVA and Kruskal-Wallis statistics), but not 
for U1 cells plus PBMCs or U1 cells plus PBMCs and C. trachoraatis. 
cells cultured with chlamydia alone was  similar  to that by 
U1 or HIV-infected patients' cells, which was, respectively, 
low or absent. 
Effect of PMNs, PBMCs, and C. trachomatis on Chronically 
HIV-infected  T  and B  Cell Lines.  The interactions between 
PMNs or PBMCs and chronically HIV-infected T  and B cell 
lines were investigated. PMNs enhanced HIV replication by 
ACH-2 T  cells.  Basal HIV p24 antigen production by 2  x 
10  s ACH-2 cells at 24, 48, and 72 h was 125  _  40, 382  _+ 
85, and 850  _+  95 pg/ml,  respectively (n  --  3).  Cocuhure 
of 2  x  10 s ACH-2 cells with 2  x  106 PMNs increased HIV 
p24 antigen production by 5-, 14-, and 12-fold, respectively 
(p <0.05  compared with basal).  In Fig.  4,  lower numbers 
of ACH-2 cells at 2  x  104 were used to study the interac- 
tion of ACH-2 cells with PMNs or PBMCs and C. tracho- 
matis and to approximate the ratio of HIV-infected cells to 
PMNs  present in semen.  Basal production  of p24  antigen 
by 2  x  104 ACH-2 cells was very low even at 48 and 72 h 
of culture. HIV p24 antigen production by ACH-2 cells cocul- 
tured with PMNs or with PMNs and chlamydia was increased 
by 8- and 12-fold, respectively (p <0.05 compared with basal). 
In contrast, PBMCs or PBMCs with chlamydia had less effect 
on HIV replication by ACH-2 cells.  The ability of PMNs 
or PMNs with chlamydia to increase HIV replication by B- 
HIV1 cells, a chronically HIV infected B cell line, was simi- 
larly observed (n  =  2;  data not  shown). 
Effect of CMV-negative PMNs on HIV replication.  CMV 
infects both PBMCs  and  PMNs  and  has been  reported to 
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Figure 4.  The effect  of PMNs or PBMCs from HIV-seronegative  donors 
and C. trachomatis on HIV replication by T cell lines. Illustrated is the 
time-dependent production of p24 antigen by ACH-2, chronically HIV- 
infected T cells. ACH-2 (2 x  104)  and B-HIV1 (2 x  104)  cells in medium 
lacking Ib2 were cultured with PMNs (2  x  106) or PBMCs (2  x  106) 
and with or without five IDs0s of C. trachomatis (Ct.).  Compared with 
ACH-2 cells alone, significantly greater amounts of p24 antigen were 
demonstrated  in ACH-2 cells  cocuhured  with PMNs but not with PBMCs. 
Chlamydia additionally increased p24 antigen production by ACH-2 cells 
cocultured with PMNs and not with PBMCs (p <0.05, Student's t test, 
n = 4). For B-HIV1 cells, experiments were conducted in medium con- 
taining 1% FBS and similar results were observed  (n = 2; data not shown). 
enhance HIV replication (33, 34, 37). Although both PMNs 
and  PBMCs  harbor  CMV  during  acute  CMV  infection, 
PBMCs  are the major reservoir after the acute phase,  and 
PMNs  have been shown  to be free of CMV by PCR even 
in CMV IgG-seropositive persons (34, 38).  To exclude the 
involvement of CMV carried by PMNs in the enhancement 
of HIV replication, PMNs, obtained from donors who tested 
negative for CMV by serology, and HL60 promyelocytes were 
further tested for CMV by PCR using oligonucleotide primers 
and probe for the IEA  gene of CMV.  HEFs infected with 
a strain of CMV and one of six (17%) PBMC samples from 
CMV-seropositive laboratorians were positive for CMV DNA 
by PCR  and Southern analysis,  whereas  PMNs  from four 
CMV-seronegative donors, five CMV-seronegative laboratory 
workers, and HL60 cells were negative. CMV-negative PMNs 
similarly enhanced HIV p24 antigen production by U1 cells 
and  ACH-2  cells  (n  =  3  CMV-seronegative  and  IEA 
gene-negative donors).  Basal p24 antigen production by 2 
￿  104 U1  cells was  50  _+  32 pg/ml at 48 h  of coculture. 
In the presence of PMNs  from CMV-seronegative donors, 
HIV p24 antigen  increased 25-fold (1,250  _+  150 pg/ml). 
ROIs Generated by PMNs or U1 Cells Trigger Viral Replica- 
tion.  PMNs are recruited into the genital tract by chlamydia 
infection. Since PMNs and mononuclear phagocytes generate 
ROIs during phagocytosis of microbes, we evaluated whether 
ROIs are also generated when PMNs from HIV-seronegative 
donors interact with HIV-infected U1 cells (Fig. 5). Unstimu- 
lated U1 cells or PMNs produced small amounts of superoxide 
that correlated with cell numbers (Fig. 5 A). PMA, a stimulus 
known  to induce  the  oxidative burst,  triggered  rapid  su- 
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F~  Figure  5.  Induction  of oxidative 
burst  activity by U1  cells.  PMNs  or 
PBMCs (cell number per well as indi- 
cated) from HIV-seronegative  donors  in 
medium or cocultured  with U1 cells (2 
x  10  3 per well), or U1  cells (cell 
number per well as indicated) were 
stimulated or not with PMA (5/~M) 
for the designated time. All conditions 
were  assayed  in triplicate, and superaxide 
production by U1 cells or in response 
to U1 coculture  is illustrated (n = 3-6). 
peroxide production by PMNs, whereas U1 cells required more 
than 2 h (Fig. 5 B). When measured after 24 h of PMA stim- 
ulation,  U1 cells generated 24.6  +  2.1 nmol of superoxide 
per  2  x  10  s cells,  an  amount  1.5-fold  greater  than  basal 
production (n  =  3). SOD abrogated both PMA-stimulated 
and basal production of superoxide by U1 cells. Cocultures 
of 2  x  10  s PMNs with 2  x  103 U1 cells triggered amounts 
of superoxide that were greater than those for either cell alone 
(Fig.  5, C and D). Superoxide production by PMNs and U1 
cells  was significantly higher  than  that  by U1 cells  cocul- 
tured with PBMCs at the same cell concentration (p <0.05, 
Student's t test, n =  3; Fig. 5, C and D). The higher produc- 
tion of superoxide by PMNs was further increased by PMA. 
The larger amount of ROIs produced by PMNs may explain 
the  greater  production  of p24  antigen  induced  by  HIV- 
seronegative PMNs than by PBMCs in cocultures with HIV- 
infected patients' mononuclear cells (Fig.  1). The induction 
of superoxide production from PMNs and monocytic cells 
was not dependent on HIV infection, since PMNs cocultured 
with  HIV-uninfected parental  cells,  U937 monocytic cells, 
or A3.01  T  cells  generated  amounts  of superoxide similar 
to those generated by PMNs cocultured with U1 cells (n  = 
2;  data not  shown). 
We next examined whether ROIs produced endogenously 
or delivered by PMNs induced HIV replication, because ex- 
ogenously added hydrogen peroxide is reported  to trigger 
HIV replication in an HIV-infected T  cell line (39-41).  To 
provide  evidence  that  ROIs  mediate  increasing  HIV p24 
production,  SOD and CAT were used, because SOD cata- 
lyzes the transformation of superoxide to hydrogen peroxide 
and CAT breaks down hydrogen peroxide to molecular ox- 
ygen and water. Fig. 6 illustrates  the effect of exogenous SOD 
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and CAT on HIV p24 antigen production.  In the presence 
of SOD and CAT,  the production of HIV by U1 cells trig- 
gered by PMA was reduced by >92%  at  72 h.  For cocul- 
tures of PMNs with U1 cells, SOD and CAT blocked viral 
production by 49-69% (p < 0.05, Student's t test, n =  9-12; 
Fig. 6, C and/9).  Individually, SOD or CAT were slightly 
less effective.  Removal of ROIs by SOD and CAT resulted 
in diminished HIV replication because in the presence of heat- 
inactivated CAT and SOD, U1 cells stimulated with PMA 
or cultured with PMNs produced HIV at levels comparable 
to control levels (n  --  4  and 6,  respectively). 
To evaluate the role of ROIs in the enhancement of HIV 
replication, the HL60 promyelocytic cell line was used. HL60 
cells have been shown to produce undetectable amounts of 
superoxide, which was also confirmed in our laboratory (31). 
Culture of HL60 cells with 1.3% DMSO for 6-9 d resulted 
in cell differentiation associated with basal and PMA stimu- 
lated superoxide production. Basal and PMA (1 #M)-induced 
superoxide production by immature  HL60 versus DMSO- 
differentiated HL60 cells was 0.6 _+ 0.2 and 0.4 +  0.2 versus 
0.6  _+  0.3 and 38.2  _+  3.2 nmol per 2  x  10  s cells at  120 
min (n  =  2, mean  +  SD). Therefore, DMSO-differentiated 
HL60 cells required PMA to trigger the production of su- 
peroxide,  as previously reported  (31). 
To evaluate the contribution of ROIs in the induction of 
HIV replication, U1 cells (2  x  104) were cultured with im- 
mature  HL60  or  DMSO-differentiated  HL60  cells  (2  x 
106). At  48  h,  basal  p24  antigen  production  by U1  cells 
cocultured with immature HL60 cells was 106  _+  73 (n  = 
2, mean +  SD). To induce maximal production of superoxide, 
DMSO-differentiated HL60 U1 cells were stimulated with 
PMA (1/~M) for 5 min and washed twice to remove PMA. w 
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Figure  6.  The effect of CAT and SOD on HIV replication.  U1 cells (2  x  104) were stimulated  with PMA (50 ng/ml) or PMNs (2  x  106) from 
HIV-seronegative  donors  in complete medium or medium containing SOD (300 U/ml), CAT (58 ~g/ml), or heat-inactivated  SOD (300 U/ml) and 
CAT (58/~g/ml). One-half volume supernatant  was exchanged daily with either medium or medium containing SOD, CAT, or heated SOD  +  CAT. 
Illustrated  is the production of p24 antigen by U1 cells stimulated  by PMA or by PMNs (A and C, respectively) and the percent inhibition by either 
SOD, CAT, or SOD  +  CAT (B and D, respectively). SOD  +  CAT significantly inhibited  p24 antigen production by U1 cells stimulated  by PMA 
or PMNs (p <0.05, Student's  paired t test,  n  =  9 and  12, respectively). Production  of p24  antigen in cocultures  containing heated SOD  +  CAT 
was comparable  to that by cells stimulated  with PMNs or PMA (n  =  6 and 4,  respectively). 
HIV p24 antigen  production by U1 cells cocultured with 
DMSO-matured and PMA-stimulated  HL60 cells was en- 
hanced by 25-fold  (5,853  +  390 pg/ml).  The addition  of 
300 U/ml SOD and 58/~g/ml CAT to DMSO-matured and 
PMA-stimulated  HL60 cells abrogated the enhancement  and 
resulted in p24 antigen production similar to that of chroni- 
cally HIV-infected cells cocultured with immature HL60 cells 
or DMSO-matured HL60 cells: respectively,  487 _+ 245 versus 
106  +  73 or 152  +  107pg/ml(n  =  2,  mean  _+  SD). 
Contact between  PMNs and U1 Cells  Is Required  for Induction 
of HIV Replication.  To characterize further the mechanism 
for the induction of HIV replication,  exogenous  hydrogen 
peroxide was added to U1 cells. However, exogenously added 
hydrogen peroxide from 10/~M to 3 mM did not stimulate 
the production of p24 antigen.  To explain this finding,  we 
examined whether cell-cell contact and local delivery of ROIs 
triggered HIV replication  (Table 2). PMNs separated from 
U1 cells by a 0.2-#m membrane insert (Millipore Corp.) and 
PMNs disrupted by freeze-thawing had no effect on HIV 
replication in U1 cells. Therefore, the induction of HIV repli- 
cation by PMNs requires direct contact between U1 cells and 
viable PMNs to deliver ROIs. 
Production of Soluble Factor by PMNs Cocuhured with U937 
Promonocytic Cells.  Since  exogenous SOD and CAT did not 
completely inhibit p24 antigen production induced by PMNs, 
experiments were performed to evaluate whether contact be- 
tween PMNs and  monocytic cells triggered the release of 
soluble factors. For these experiments  we used U937 cells, 
the monocytic cell line from which U1 cells were derived 
after infection with a molecular clone of HIV. CeU-free su- 
pernatants  from cocultures  of PMNs and U937 cells, when 
added to U1 cells, induced a time-dependent  increase in HIV 
p24 antigen  (p <0.05, ANOVA; Table 2; Fig. 7). Superna- 
tants from cocultures of freeze-thawed PMNs and U937 cells 
had no effect on HIV replication  by U1 cells. Furthermore, 
p24 antigen  production by U1 cells treated  with superna- 
tants  from cocultures  of PMNs and U937 cells containing 
SOD and CAT was reduced by 57% (p <0.05, ANOVA and 
Kruskal-Wallis statistic, n =  4). The maximum residual SOD 
and CAT may be 6.25%  at the end of culture,  since these 
enzymes were not additionally added to U1 cells. To evaluate 
whether soluble factors were present  in the supernatant  of 
PMN and U937 cocultures, fractionation of the supernatant 
was performed using molecular sieve  centrifugation  (Amicon 
1500  Neutrophils from HIV-uninfected  Persons Induce  HIV Replication Table  2.  Induction of HIV Replication of UI  Cells Requires 
Contact with PMNs from HIV-Seronegative Donors 
HIV p24 antigen 
production  (pg per ml) 
by U1  cells 
Conditions  24 h  48 h 
PMNs  128  +  64  1,883 +  312 
Membrane-separated PMNs  0  0 
Freeze-thawed PMNs  0  0 
Supernatant  of PMNs  +  U937 cells 327  _+  199  1,655 _+  454 
PMNs (2  x  106), freeze-thawed  PMNs (10  x,  -70~  and PMNs 
separated from U1 cells  by a 0.2-/~m membrane  insert (Millipore  Corp.) 
were cultured with U1 cells (2  x  104). Cell-free  supernatant (0.75 ml) 
from cocultures of PMNs (2  x  106) and U937 cells (2  x  104) at 48 h 
were added to U1 cells (2  x  104, total volume  of 1.5 ml), and one-half 
volume exchanges  with complete  medium were performed.  The amounts 
of p24 antigen in the supernatants were assayed. Constitutive produc- 
tion of p24 antigen by U1 cells was subtracted from each condition (n 
=  2-6). 
centrifugation system). Over 90% of the activity for induc- 
tion of p24 antigen production by U1 cells resided in the 
<30,000 molecular size fraction of the coculture supernatants 
from PMNs  and U937 cells  as compared with the higher 
molecular size fraction (n  =  2). 
Induction  of TNF-cr and IL.6.  The finding of a soluble 
factor(s) in the supernatant of PMN and U937 cell cocul- 
tures that enhanced p24 production by U1 cells led to the 
measurement of TNF-o~ and IL-6. These cytokines have been 
reported to enhance HIV production by U1 cells (42-44). 
Assays for TNF-c~ and I1:6 were performed on stored super- 
natants from HIV-infected patients' mononuclear cells cocul- 
tured with HIV-uninfected PMNs or PBMCs (Fig. 1), from 
PMN and U1 cell cocultures (Table 2), and from PMN and 
U937 cell cocultures (Fig.  7). A time-dependent increase in 
TNF-cr and I1:6 was observed in the supernatants of PMNs 
or PBMCs from HIV-seronegative donors cocultured with 
HIV-infected patients' mononuclear cells (p <0.05 ANOVA, 
n  =  4 separate patients; Fig.  8 A). The kinetics of TNF-oL 
and I1:6 generation in Fig. 8 A  paralleled those of p24 an- 
tigen production illustrated in Fig. 3. TNF-c~ and I1:6 were 
assayed in the supernatants of the U1 and PMN cocultures 
from experiments presented in Table 2.  A  fivefold increase 
was observed in TNF-c~, and IL-6 was observed between 24 h 
and 72 h in U1 cells cocultured with PMNs but not with 
disrupted (freeze-thawed) PMNs  (n  =  3;  Fig.  8 B).  The 
amounts of cytokines detected paralleled p24 antigen produc- 
tion shown in Table 2. 
Supernatants of the U937 cells and PMNs from experi- 
ments illustrated in Fig.  7 were assayed for TNF-o~ and I1:6. 
High levels of TNF-ot and 11:6 were found in the superna- 
tants from cocultures of PMNs and U937 cells but not in 
supernatants of cocultures of disrupted PMNs and U937 cells 
(n  =  8;  Fig.  8 C).  Furthermore, SOD and CAT,  but not 
heated SOD/CAT abrogated the production of TNF-c~ and 
II:6 by PMNs and U937 cells (p <0.05 compared with no 
SOD or CAT, Student's t test, n  -- 3 separate experiments). 
In contrast, the amount of p24 antigen produced by U1 cells 
triggered by supernatants  from U937 cells  and  PMNs  in 
medium containing SOD/CAT was decreased by 53% (Fig. 
7). These results suggested that additional factors are involved 
in the induction of HIV replication. 
Discussion 
In this in vitro model, PMNs from HIV-seronegative donors 
induced HIV replication by mononuclear cells of HIV-infected 
patients even in the absence of I1:2. PMNs triggered HIV 
replication, because mononudear cells from HIV-infected pa- 
tients cultured alone did not produce measurable p24 antigen 
and because the addition of fresh PMNs was required to sus- 
tain the production of p24 antigen. PMNs also enhanced HIV 
replication by three different lineages of chronically HIlT- 
infected cell lines.  C.  trachomatis in the presence of PMNs 
further enhanced HIV p24 production by U1 and other chron- 
ically HIV-infected cell lines; in contrast, C. trachomatis without 
PMNs  had no independent effect on HIV replication. 
Although these experiments strongly implicate PMNs as 
a mediator of viral replication, the possibility that dendritic 
cells are involved is not excluded. The finding that the PBMC 
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Figure  7.  The effect  of SOD and CAT on the production  of a soluble 
factor(s) from U937 cells cocultured  with PMNs from HIV-seronegative 
donors. The promonocytic  U937 cells not containing  HIV (2 x 104)  were 
cocultured with PMNs or freeze-thawed (F/T) PMNs (2  x  104) in 
medium or in medium containing  300 U/ml SOD and 58/~g/ml CAT 
(SOD/CAT) or heat-inactivated  SOD/CAT. At 48 h of culture, cell-free 
supernatants (750 ml) from each of these conditions were added to HIV- 
infected  U1 cells. Increasing  amounts  of p24 antigen  were  detected  in cocul- 
tures of U1 cells with supernatants from PMNs + U937 cell, or PMNs 
+ U937 cells + heated-SOD/CAT,  but were not detected  in coculture 
of U1 cells with supernatants from freeze-thawed  PMNs + U937 cells 
(p <0.05, ANOVA, n =  4). The presence of SOD/CAT in the PMN 
and U937 cocultures reduced  p24 antigen production  by U1 cells (com- 
pared with no SOD/CAT; p <0.05, ANOVA, n =  4). 
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Figure 8.  The production of TNF-(x  and Ib6. Illustrated  is the amount 
of  TNF-c~  and I1:6 measured  in coculture  supernatants of PMNs or PBMCs 
from HIV-seronegative  donors with mononudear cells of HIV-infected 
patients (Fig. 1), PMNs with U1 cells (Table 2), and PMNs with U937 
cells (Fig. 7). A time-dependent production of TNF-c~ and Ib6 was de- 
tected in supernatants of HIV-infected  patients' mononuclear cells cocul- 
tured with PMNs or PBMCs (A) and in supernatants of U1 cells cocul- 
tured with PMNs but not with freeze-thawed  (F/T) PMNs (B) (p <0.05, 
Student's t test for four separate patients each with two donors and three 
separate U1 experiments). Similar  levels of TNF-(x and Ib6 were detected 
in supernatants from PMNs and U937 cells cocuhured in medium or in 
medium containing heat-inactivated  300 U/ml SOD and 58 ~g/ml CAT. 
(C) Barely detectable amounts of TNF-o~ and 11.-6 were found, respec- 
tively, in supernatants of U937 ceils cocuhured with PMNs in the pres- 
ence of SOD/CAT and with freeze-thawed  PMNs (n = 3). One-half  volume 
medium was changed every 2-4 d for harvest (H) intervals 1-5. 
fraction, which contains most of the dendritic cells in blood, 
was less effective than PMNs  in inducing HIV replication 
in patients' cells and cell lines suggests that the PMN is an 
inducer of HIV replication. In addition, it may not be neces- 
sary to exclude a role of dendritic cells in these in vitro ex- 
periments because the inflammatory exudate of STDs in the 
genital tract is likely to have dendritic cells present as a result 
of recruitment  or breakdown  of the mucosa. 
Cell-free myeloperoxidase of PMNs has been reported to 
inactivate HIV in vitro (36). Our data indicate that HIV in 
the cell-free supernatant from cocuhures of PMNs and pa- 
tient PBMCs was replication competent. Evidence for repli- 
cation  competence included  the propagation  of virus in  a 
second round of viral culture and the detection ofHIV provirus 
in the nuclear extracts from these cells, indicating the reverse 
transcription of viral RNA to DNA. HIV may have remained 
infectious despite the presence of PMNs because of one or 
more of the following reasons:  (a) most  of the virus is in 
the  fluid  phase  whereas  myeloperoxidase is  usually  found 
within phagolysosomes; (b) extracellular myeloperoxidase may 
be less active in the presence of 10%  FBS compared with 
serum-free conditions previously reported (36); and (c) the 
amounts of virus produced may have overwhelmed the avail- 
able myeloperoxidase. 
Epidemiologic studies have defined that concurrent infec- 
tion with many STDs, and in particular C. trachomatis infec- 
tion, is associated with subsequent HIV seroconversion. How- 
ever, a causal relationship between coinfection with other STDs 
and enhanced HIV transmission has not been demonstrated. 
Our findings suggest that PMNs trigger HIV replication by 
HIV-infected mononudear cells and that C. trachomatis in the 
presence of PMNs  additionally enhances  HIV  replication. 
Based on these in vitro observations, it is likely that women 
with  a chlamydia infection have an increased risk for HIV 
infection because PMNs  recruited by C.  trachomatis induce 
the production of infectious viruses from the HIV-infected 
sex partner's mononuclear cells ejaculated in semen. Chlamydia 
in this environment may further augment HIV replication. 
Since PMNs  from HIV-seronegative persons enhance HIV 
replication, it is possible that recruitment of PMNs into the 
female genital tract by any etiology may increase the risk for 
HIV transmission.  Thus,  the presence of PMNs  may con- 
tribute to the increased risk for HIV seroconversion in women 
with trichomoniasis or gonorrhea (1, 7, 45, 46). Not exam- 
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an HIV-infected individual enhance HIV replication, making 
the genital secretions from persons coinfected with HIV and 
another STD more infectious. 
One mechanism by which PMNs induced HIV replica- 
tion is the generation of ROIs, because exogenous SOD and 
CAT partially or completely abrogated p24 antigen produc- 
tion induced by PMNs, PMA, or differentiated HL60 cells 
stimulated with PMA. The finding that local delivery of ROIs 
by PMNs triggered HIV replication extends the previous ob- 
servations that exogenously added hydrogen peroxide induced 
HIV replication (39, 40). These investigators demonstrated 
that HIV replication induced by hydrogen peroxide is medi- 
ated by NF-rB transcriptional  regulatory proteins (40, 41). 
In contrast to these reports,  in our system the exogenous 
hydrogen peroxide did not induce HIV p24 antigen produc- 
tion. It is possible that the presence of 10%  serum in the 
culture medium may have reacted with ROIs and therefore 
reduced the amount of ROIs reaching HIV-infected cells. It 
is possible that HIV-infected  monocytic cells used in our system 
behave differently from T cell lines (39, 40). The failure of 
hydrogen peroxide to replace PMNs when SOD and CAT 
partially blocked the action of PMNs suggests that ROIs are 
necessary but not sufhcient.  Cell-cell contact may provide 
the necessary stimulus because p24 antigen production was 
abrogated in cocultures of U1 cells separated from PMNs by 
a porous membrane (Table 2). In this setting C. trachornatis 
triggers  greater p24 antigen production because of greater 
amounts of tLOIs generated by PMNs during phagocytosis 
of the microbe. 
In addition to R.OIs, cell-cell contact may provide another 
signal for the induction of  HIV replication. This is supported 
by the lack of viral replication when U1 cells were separated 
by a membrane from PMNs or cocultured with disrupted 
PMNs. Furthermore, in cocultures of U1 cells with PMNs, 
SOD and CAT inhibited only 69%  of HIV p24  antigen 
production (Table 2; Fig. 6 B). In contrast,  SOD and CAT 
inhibited  >92% of the p24 production triggered by PMA 
(Fig. 6 A). 
Cell-cell interaction also triggers the production of cyto- 
kines, such as TNF-ot  and IL-6, that feed back to enhance 
HIV production (42-44). Large amounts of TNF-o~ and II.-6 
were detected in supernatants of cocultures containing PMNs 
with either patient mononuclear, U1, or U937 cells (Fig. 8, 
A-C). Under these coculture conditions, the time course and 
the amounts of HIV p24 antigen generated paralleled the 
production of these cytokines (Figs. 1 and 7; Table 2). The 
production of II~6 and TNF-c~ was also inhibited by SOD 
and CAT. In addition to TNF-ot and IL-6, other soluble factors 
are present because the supernatants from coculture ofU937 
cells and PMNs in medium containing SOD and CAT had 
barely detectable amounts of these cytokines while remaining 
able to induce p24 antigen at a level that was '~50% of the 
levels in PMN and U937 cell coculture without SOD and CAT. 
These observations provide support for programs that target 
the prevention and prompt treatment of all STDs (7, 45, 46). 
Condoms, spermicides, or the combination have been advo- 
cated to reduce STD and HIV transmission (47-55).  Clin- 
ical trials of nonoxynol-9, the major active ingredient of sper- 
micides, have not conclusively demonstrated its  ability to 
prevent HIV transmission (49, 56) probably because of the 
narrow therapeutic and toxicity range, since the mode of ac- 
tion of nonoxynol-9 is the disruption of cell membranes. 
Studies should be conducted to identify new agents with the 
ability to prevent STD and HIV transmission while preserving 
mucosal integrity and to define ways of maintaining healthy 
female genital epithelium.  Our results suggest that local use 
of antioxidants  should also be evaluated for their potential 
to decrease HIV replication and reduce HIV transmission. 
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